Vaccination reduces transmission to unvaccinated household members by 63% for Delta variant Vaccination protects against COVID-19, and also reduces the risk of transmitting the virus to others.
4 in 5 COVID-19 patients in ICU are not vaccinated 4 in 5 COVID-19 patients in intensive care are not vaccinated against the coronavirus SARS-CoV-2.
Expected autumn increase in SARS-CoV-2 appears to have started In the past week from 5-12 October 2021, the reported number of people who tested positive for COVID-19 increased by 48% compared to the previous week. Reported figures increased in all regions and in all age groups.
More than health risks play a role in compliance with coronavirus measures The risk of COVID-19 is not the only factor that determines compliance with the coronavirus measures; other risks also play a role.
No evidence of more serious illness from COVID-19 among Q fever patients There are no indications that people who previously had Q fever had a more serious course of illness from the coronavirus SARS-CoV-2. This is evident from RIVM research.
Specific group of patients with impaired immunity invited in October for third COVID-19 vaccination From 6 October on, a specific group of people with severely impaired immunity (immunocompromised patients) will receive their invitation for a third vaccination against COVID-19.
Vaccination turnout for people aged 25-44: 66% vaccinated at least once The 26th RIVM vaccination update now shows vaccination turnout for people aged 25-44 years by municipality. This involves people who have received at least one COVID-19 vaccination.
More attention needs to be paid to the safe recycling of waste According to the National Institute for Public Health and the Environment (RIVM) there needs to be a greater (international) focus on, and increased awareness of, the safe recycling of waste.
Heterologous vaccination from 16 July on Following an advisory report by the Health Council, Minister De Jonge decided on 6 July 2021, effective as of 16 July, that people who had received one vaccination with AstraZeneca could opt for the Pfizer/BioNTech for their second jab.
Vaccination coverage is rising, while data is increasingly comprehensive The RIVM vaccination update this week has been expanded to include vaccination coverage by municipality, specifying full COVID-19 vaccination among people aged 65 and over and people aged 45-64 years.